[go: up one dir, main page]

MX2009005003A - Composicion que comrpende (-)-.?9-trans-tetrahidrocannabinol. - Google Patents

Composicion que comrpende (-)-.?9-trans-tetrahidrocannabinol.

Info

Publication number
MX2009005003A
MX2009005003A MX2009005003A MX2009005003A MX2009005003A MX 2009005003 A MX2009005003 A MX 2009005003A MX 2009005003 A MX2009005003 A MX 2009005003A MX 2009005003 A MX2009005003 A MX 2009005003A MX 2009005003 A MX2009005003 A MX 2009005003A
Authority
MX
Mexico
Prior art keywords
tetrahydrocannabinol
sup
trans
composition
acid
Prior art date
Application number
MX2009005003A
Other languages
English (en)
Inventor
Ronald Rossi
Lee Jonathan Silverberg
Robert Hogan
Ramesh Shan
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Publication of MX2009005003A publication Critical patent/MX2009005003A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición que comprende un compuesto de tetrahidrocannabinol, un solvente y un ácido, donde el compuesto de tetrahidrocannabinol puede ser ?8-tetrahidrocannabinol, (-)-?9-trans-tetrahidrocannabinol o un derivado de alquilo de cadena lateral de cualquiera de los compuestos, el solvente puede ser un aceite o alcohol de C1-C4 (p. ej., aceite de ajonjolí o etanol), y el ácido puede ser un ácido orgánico o un ácido mineral.
MX2009005003A 2006-11-10 2007-11-09 Composicion que comrpende (-)-.?9-trans-tetrahidrocannabinol. MX2009005003A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/595,682 US8039509B2 (en) 2006-11-10 2006-11-10 Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
PCT/EP2007/062174 WO2008055992A1 (en) 2006-11-10 2007-11-09 Composition comprising (-)-δ9-trans-tetrahydrocannabinol

Publications (1)

Publication Number Publication Date
MX2009005003A true MX2009005003A (es) 2009-06-12

Family

ID=39149274

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005003A MX2009005003A (es) 2006-11-10 2007-11-09 Composicion que comrpende (-)-.?9-trans-tetrahidrocannabinol.

Country Status (9)

Country Link
US (4) US8039509B2 (es)
EP (1) EP2086954B1 (es)
JP (1) JP5453096B2 (es)
CN (1) CN101578276A (es)
AU (1) AU2007316584B2 (es)
CA (1) CA2669021A1 (es)
IL (1) IL198651A (es)
MX (1) MX2009005003A (es)
WO (1) WO2008055992A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039509B2 (en) 2006-11-10 2011-10-18 Johnson Matthey Public Limited Company Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
US8980940B2 (en) 2006-11-10 2015-03-17 Johnson Matthey Public Limited Company Stable cannabinoid compositions and methods for making and storing them
EP2642982A2 (en) 2010-11-22 2013-10-02 Johnson Matthey Public Limited Company Stable cannabinoid compositions and methods for making and storing them
US8741341B2 (en) * 2012-05-07 2014-06-03 Insys Therapeutics, Inc. Manufacturing and packaging room temperature stable dronabinol capsules
DE102012105063C5 (de) * 2012-06-12 2023-09-14 Thc Pharm Gmbh The Health Concept Stabilisierung von Cannabinoiden und deren pharmazeutischen Zubereitungen
CN103110582A (zh) * 2013-03-04 2013-05-22 上海医药工业研究院 大麻酚类化合物微乳剂及其制备方法
CA3111682A1 (en) 2014-06-26 2015-12-30 Island Breeze Systems Ca, Llc Mdi related products and methods of use
USD772284S1 (en) * 2014-09-01 2016-11-22 Apple Inc. Display screen or portion thereof with a set of graphical user interfaces
EP3215148B1 (en) 2014-11-03 2022-04-13 Ramot at Tel-Aviv University Ltd. Use of low dose of tetrahydrocannabinol for the treatment of cognitive decline in elderly patients
USD776682S1 (en) * 2015-09-04 2017-01-17 Salesforce.Com, Inc. Display screen or portion thereof with animated graphical user interface
USD801377S1 (en) * 2015-09-28 2017-10-31 ProductionPro LLC Display panel with transitional graphical user interface
US10272360B2 (en) 2017-08-05 2019-04-30 Priya Naturals, Inc. Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
KR102652605B1 (ko) 2017-08-27 2024-03-28 로드스 테크놀로지즈 안과 질환 치료를 위한 약학제적 조성물
TW202228673A (zh) * 2020-09-24 2022-08-01 英商尼可創業貿易有限公司 調配物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726916D0 (en) 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
US6403126B1 (en) 1999-05-26 2002-06-11 Websar Innovations Inc. Cannabinoid extraction method
GB0112752D0 (en) 2001-05-25 2001-07-18 Johnson Matthey Plc Synthesis of cannabinoids
WO2003006010A1 (en) * 2001-07-10 2003-01-23 Norton Healthcare Limited Aerosol formulations of δ8 tetrahydrocannabinol
EP1515711A1 (en) * 2002-06-22 2005-03-23 Norton Healthcare Limited Pharmaceutical composition
PT2314284T (pt) 2002-08-14 2017-05-25 Gw Pharma Ltd Formulações líquidas de canabinoide para administração mucosal
US20040229939A1 (en) * 2003-02-14 2004-11-18 Chowdhury Dipak K. Tetrahydrocannabinol compositions and methods of manufacture and use thereof
GB0329635D0 (en) 2003-12-23 2004-01-28 Johnson Matthey Plc Process for purifying trans-tetrahydrocannabinol
TWI436991B (zh) 2004-11-22 2014-05-11 Euro Celtique Sa 用於純化反-（-）-△９-四氫大麻酚與反-（＋）-△９-四氫大麻酚之方法
EP1827393A4 (en) 2004-12-09 2012-04-18 Insys Therapeutics Inc AT ROOM TEMPERATURE, STABLE DRONABINOL FORMULATIONS
TWI366460B (en) * 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
AU2006297300B2 (en) * 2005-09-29 2012-05-10 Albany Molecular Research, Inc. Process for production of delta-9-tetrahydrocannabinol
BRPI0715328A2 (pt) * 2006-08-04 2013-07-09 Insys Therapeutics Inc formulaÇço, e, dispositivo de dose unitÁria ou de dose méltipla para a administraÇço sublingual de uma droga
EP1927582A1 (en) 2006-11-07 2008-06-04 Cytec Surface Specialties, S.A. Coatings for ceramic substrates
US8039509B2 (en) 2006-11-10 2011-10-18 Johnson Matthey Public Limited Company Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
US20090181080A1 (en) 2007-08-06 2009-07-16 Insys Therapeutics Inc. Oral cannabinnoid liquid formulations and methods of treatment

Also Published As

Publication number Publication date
AU2007316584B2 (en) 2013-02-14
EP2086954B1 (en) 2013-07-24
US8906956B2 (en) 2014-12-09
JP2010509292A (ja) 2010-03-25
US8476312B2 (en) 2013-07-02
CA2669021A1 (en) 2008-05-15
JP5453096B2 (ja) 2014-03-26
IL198651A (en) 2014-09-30
WO2008055992A1 (en) 2008-05-15
US20130345299A1 (en) 2013-12-26
US20080139644A1 (en) 2008-06-12
EP2086954A1 (en) 2009-08-12
US8039509B2 (en) 2011-10-18
US20120322866A1 (en) 2012-12-20
AU2007316584A1 (en) 2008-05-15
CN101578276A (zh) 2009-11-11
IL198651A0 (en) 2010-02-17
US20120010279A1 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
MX2009005003A (es) Composicion que comrpende (-)-.?9-trans-tetrahidrocannabinol.
PA8660001A1 (es) Amino-imidazolonas para la inhibicion de b-secretasa
DK2078010T3 (da) Polycyklisk heteroaryl-substituerede triazoler, der er anvendelige som axl-hæmmere
ATE535533T1 (de) Schmieröl- und brennstoffzusammensetzungen
UY31177A1 (es) Agentes de naftalenisoxazolina para el control de plagas de invertebrados
MX2009005934A (es) Compuestos organicos.
TW200706519A (en) Pyrene derivatives and organic electronic device using pyrene derivatives
UY31633A1 (es) Plaguicidas mesoiónicos
TW200709886A (en) Fluxing compositions
EP2055762A3 (en) Lubricating oil compositions comprising a biodiesel fuel and an antioxidant
WO2009156462A3 (en) Organic compounds
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
WO2009147031A3 (en) Oxime ester photoinitiators
DK1776011T3 (da) Fungicid sammensætning, indeholdende et syreamidderivat
AR061134A1 (es) Derivados de tioxantina
AR062211A1 (es) Derivados de 6-carboxi-normorfinano. composiciones farmaceuticas
AR082343A2 (es) Un metodo de reduccion de desgaste por rozamiento para combustibles y procedimiento para preparar una composicion combustible
WO2008071928A3 (en) Corrosion inhibitor intensifier compositions and associated methods
GT200800251A (es) Nitrilos espirociclicos como inhibidores de proteasa
BRPI0914384A2 (pt) método para produzir pelo menos um composto desejado, uso pelo menos um composto substituinte, método para produzir um composto derivado, composto n-alcóxi-hexanodiol, método de produção de um composto, uso do composto, composto que possui pelo menos 37% de origem biológica e composto derivado
WO2006052568A3 (en) Tgf-beta inhibitors
WO2008086326A3 (en) Organic solderability preservative comprising high boiling temperature alcohol
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
WO2007103508A3 (en) Ligands for nematode nuclear receptors and uses thereof
WO2011012247A8 (de) 2-(3-alkylthiobenzoyl)cyclohexandione und ihre verwendung als herbizide

Legal Events

Date Code Title Description
FG Grant or registration